Batu Biologics files Right to Try Patent

Batu Biologics Files Patent on Patient Selection for Right to Try Law

Clinical Stage Immunotherapy Company Creates System of Selecting Patients for Optimized Outcome under President Donald Trump’s Right to Try Law

Batu Biologics announced today filing of a patent covering methods of matching cancer patients with experimental drugs under the new Right to Try Law. The recently passed law allows for companies that have passed Phase I of clinical trial to start offering terminal patients access to drugs that are still in development.

Read the full article at businesswire.com

Leave a Reply

Your email address will not be published. Required fields are marked *